Clinical trials: Excimer Light

Vitiligo, Nonsegmental Vitiligo

Topical Ruxolitinib Versus Tacrolimus With Excimer Laser for Localized Vitiligo

• Enrolling by invitation
• Age: 12 years and older
• Medical device

This randomized comparative study will evaluate the efficacy and safety of topical ruxolitinib 1.5% cream compared with topical tacrolimus 0.1% ointment, each combined with 308-nm excimer laser therapy, in patients aged 12 years…

Trial name

NCT07909668

Testing

Tacrolimus 0.1% ointment, Ruxolitinib 1.5% cream, 308-nm excimer laser

Where

Egypt

Volunteers

40 people

Sponsor

Kafrelsheikh University